Injectable GLP-1s for obesity have been revolutionary products of the pharmaceutical industry over the past few years. Now, for the first time, the weight loss drug is being offered in pill form. Novo Nordisk’s Wegovy pill hit the market on January 5th and rival Eli Lilly has its own version currently waiting for FDA approval. Watch the video to learn why drug companies are racing to get obesity pills onto the market.
Produced, Shot and Edited by: Ryan Baker
Reporter: Annika Kim Constantino
Animation by: Emily Park
Senior Managing Producer: Tala Hadavi
Additional Footage: Getty Images, Novo Nordisk
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus
About CNBC: From ‘Wall Street’ to ‘Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Want to get ahead at work with AI? Sign up for CNBC’s new online course, Beyond the Basics: How to Use AI to Supercharge Your Work. Learn advanced AI skills like building custom GPTs and using AI agents to boost your productivity today. Use coupon code EARLYBIRD for 25% off. Offer valid from Jan. 5 to Jan. 19, 2026. Terms apply. Sign up today: https://cnb.cx/4qKBe6H
Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC
#CNBC
How Weight Loss Pills Could Reshape The GLP-1 Landscape
source
